CAS: 459836-30-7 - PEAQX
![[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate](https://static.cymitquimica.com/products/AN/thumb/AG003CQ7.jpg)
[[[(1S)-1-(4-Bromophenyl)ethyl]amino](1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl] phosphonic acid tetrasodium hydrate
CAS:459836-30-7
Formula:
C17H17BrN3Na2O6P
Purity:
95%
Color and Shape:
Solid
Molecular weight:
516.1907
Ref: AN-AG003CQ7
| 5mg | 160.00 € | |
| 10mg | 238.00 € | |
| 25mg | 325.00 € | |
| 100mg | 914.00 € | |
| 250mg | 1,825.00 € |
Estimated delivery in United States, on Friday 3 May 2024
PEAQX tetrasodium hydrate
CAS:459836-30-7
Formula:
C17H13BrN3Na4O5P·xH2O
Molecular weight:
542.14 (anhydrous)
Ref: 7W-GL2910
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 6 May 2024
PEAQX
CAS:459836-30-7
PEAQX (NVP-AAM077)(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human …
Formula:
C17H17BrN3O5P
Purity:
100%
Color and Shape:
Solid
Molecular weight:
454.21
Ref: TM-T4171
| 1mg | 50.00 € | |
| 2mg | 69.00 € | |
| 5mg | 114.00 € | |
| 10mg | 197.00 € | |
| 25mg | 353.00 € | |
| 50mg | 551.00 € | |
| 100mg | 783.00 € | |
| 1ml*10 (DMSO) | 162.00 € |
Estimated delivery in United States, on Friday 10 May 2024
PEAQX tetrasodium hydrate
CAS:459836-30-7
PEAQX tetrasodium hydrate is a new drug for the treatment of ovarian hyperstimulation syndrome (OHSS) …
Formula:
C17H13BrN3Na4O5P·xH2O
Purity:
Min. 95%
Molecular weight:
542.14 g/mol
Ref: 3D-JTA83630
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024
